Stem Cell & Regenerative Medicine

Regenerative Approaches in Diabetes & Metabolic Disorders

Regenerative medicine offers new hope for diabetes and metabolic disorders through pancreatic islet regeneration, stem cell therapies, and gene editing. Cellular interventions aim to restore insulin production, improve glucose homeostasis, and reduce complications. Strategies include differentiation of pluripotent stem cells into insulin-producing beta cells, transplantation, and immunomodulatory approaches to prevent autoimmunity. Gene editing techniques like CRISPR correct genetic defects in monogenic diabetes, while bioengineered scaffolds and encapsulation enhance cell survival and functionality. Emerging therapies target obesity, lipid metabolism, and metabolic syndrome through cellular and tissue-engineered interventions. Preclinical and clinical studies show promising improvements in glycemic control, organ protection, and systemic metabolic balance. This session highlights challenges including immune rejection, delivery efficiency, scalability, and regulatory compliance, while emphasizing the integration of precision medicine, biomaterials, and cellular therapies to create innovative solutions for patients suffering from chronic metabolic disorders.